blocker, doxazosin, on benign prostatic hyperplasia (BPH) are poorly understood. We
evaluated the effect of doxazosin on cell proliferation and apoptosis in the prostatic
glandular epithelium and stroma of patients with BPH. Materials and Methods: We examined
proliferative and apoptotic activities in prostate specimens of 22 men a mean of 65 years old
with BPH before and after doxazosin treatment within the normal therapeutic range …